Hyundai Pharmaceutical Co Ltd
KRX:004310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Hyundai Pharmaceutical Co Ltd (004310) under the Base Case is KRW per share.
Compared with the current market price of 6 510 KRW, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Hyundai Pharmaceutical Does
Hyundai Pharmaceutical Co Ltd makes medicines and health-related products in South Korea. It sells over-the-counter drugs, prescription medicines, health supplements, and sanitary or disinfectant products that people buy through pharmacies, hospitals, clinics, and other retail channels. The company’s business is built around products that are used in everyday care, such as treating minor illnesses, supporting health, and helping with hygiene.
- Headquarters
- Korea KR
- Employees
- 378
- IPO date
- Jun 28, 1978
Revenue & Expenses Breakdown
Hyundai Pharmaceutical Co Ltd
Earnings Waterfall
Hyundai Pharmaceutical Co Ltd
Continue Research
Decided on Hyundai Pharmaceutical? Get an email when Hyundai Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Hyundai Pharmaceutical Co Ltd stock?
The intrinsic value for Hyundai Pharmaceutical Co Ltd (004310) under the Base Case is KRW.
Is Hyundai Pharmaceutical Co Ltd stock undervalued or overvalued?
Compared with the current market price of 6 510 KRW, the stock appears .
